News

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...
The U.S. has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday.
The United States has approved the world’s first twice-yearly HIV prevention shot, marking a major milestone in the ...
The US FDA has approved lenacapavir, a biannual injection by Gilead, to prevent HIV, potentially revolutionizing the fight against the epidemic.
Lenacapavir, the world's first twice-yearly HIV prevention shot, gets US FDA nod-offering a discreet, long-acting solution ...
The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market ...
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
The U.S. has approved the world’s only twice-a-year shot ... in HIV infections, while rates continued rising elsewhere. About half of new infections are in women, who often need protection ...
WASHINGTON D.C., DC — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first ... of new infections are in women, who often need protection they can use without ...
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step ... of new infections are in women, who often need protection they can use without ...